Because this tumor is exceedingly rare, many studies have focused on its clinicopathologic features, while little effort has been made to study the gene abnormalities that drive this tumor.[2] Herein, we report a case of a young woman diagnosed with nasopharyngeal papillary adenocarcinoma that harbored a fusion of ROS1 with GOPC. Here, ROS1 is linked to neoplasm.